HomeUS StocksSRPT

S

Sarepta Therapeutics Inc

SRPT Share PriceUS Stock

$ 15.41

0.41 (2.70%)profit
as on 12 Jun 2026 at 08:51 PM

NASDAQ

analyst50% Hold
Overview
News
History
Fundamentals
Investment Returns
Financials
Balance Sheet
Cash Flow
Peers
Bulb

As on 12 Jun 2026 08:51 PM Sarepta Therapeutics Inc opened at $15.01 while its previous close was at $15.00. In the trading session SRPT reached a high of $15.55 and low of $15.01. The total number of shares traded is 5,84,882. Based on analyst ratings the stock has 27.78% Buy, 22.22% Sell and 50% Hold.

TradingViewarrow

SRPT Stock Performance

Markets Today

High

15.55

Low

15.01

Open at

15.01

Prev Close

15.00

Volumes

5,84,882

Price Movement

15.0115.55
2.63%Loss
down side
up side
0.93%Profit

Historical Performance

3 M High

23.85

3 M Low

14.68

1 Yr High

39.64

1 Yr Low

10.42

3 Yr High

173.25

3 Yr Low

10.42

5 Yr High

173.25

5 Yr Low

10.42

1-Year Performance

10.4239.64
47.91%Loss
down side
up side
61.13%Profit

SRPT Analyst Rating

Hold

Analysts have suggested that investors can Hold this Stock

- By ViewTrade from 18 analysts

Buy

27.78%

Hold

50%

Sell

22.22%

SRPT Latest News

SRPT Share Price History

Close Price

Volume

SRPT share price in last 10 trading sessions

DayOpenCloseChange%Day HighDay LowVolume
11 Jun 202615.1315.00
-0.86% Loss
15.1614.6822,77,661
10 Jun 202615.6715.12
-3.51% Loss
16.0515.0218,18,865
09 Jun 202615.8015.91
0.70% profit
16.2815.4115,12,717
08 Jun 202615.8015.54
-1.65% Loss
15.8815.4218,11,592
05 Jun 202616.5915.75
-5.08% Loss
16.6915.6619,78,433
04 Jun 202616.3816.67
1.77% profit
16.9016.3814,86,960
03 Jun 202616.2516.24
-0.06% Loss
16.5116.1018,36,536
02 Jun 202617.5916.25
-7.62% Loss
17.5915.9535,94,333
01 Jun 202617.6417.62
-0.11% Loss
18.2217.4021,53,963
29 May 202617.4017.88
2.76% profit
17.9917.4023,18,690

SRPT Fundamentals

Company Valuation

Market Cap

$1,626M

PE Ratio

91.10

PEG Ratio

-

PB Ratio

1.34

ROE

-54.97%

ROCE

-25.62%

SAREPTA THERAPEUTICS INC Return Calculator

You have invested
Investment Period

Current value of $10,000 invested 5 years ago, as on today

$ 0

Loss

$ 10,000 (82.09%)

Invest Now

Note: Past profits do not guarantee future returns.

SRPT Investment Returns

Short Term

1 Week

1 Month

3 Months

6 Months

Long Term

1 Year

2 Years

3 Years

5 Years

SRPT Financials Summary

Revenue
EBITDA
Net Profit
EPS
Revenue

In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
745611399443731

SRPT Financials

Income Statement

In USD

Quarterly StatementMar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue745611399443731
Expenses1,045496462853372
Operating Profit-300116-63-410358
Operating Profit Margin %-40%19%-16%-93%49%
Other Income-0-1-1-01
EBITDA-290126-44-405358
Interest833813113215
Depreciation10111850
Profit Before Tax-384154-194-278343
Tax %-17%28%-7%-2%4%
Net Profit-448197-180-283331
EPS-52-2-33

Balance Sheet

In USD

Yearly Balance SheetJun 2024Sep 2024Mar 2025Jun 2025Sep 2025
Share Capital5,4825,5895,8015,8445,987
Reserve & Surplus-4,405-4,368-4,658-4,462-4,641
Non Current Liabilities1,6591,6791,7171,4021,252
Current Liabilities688699606920921
Total Liabilities3,4243,6003,4653,6803,493
Fixed Assets400447508515498
Current Assets2,6842,6852,4332,6572,722
Total Assets3,4243,6003,4653,6803,493

Cash Flow

In USD

Quarterly Cash FlowDec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Cash from Operating92-583261-15131
Cash from Investing764-2913223296
Cash from Financing4912-24-118-39
Net Cash Flow905-862270100188

SRPT Revenue Growth

All values are in USD

Revenue

Profit

Loss

Financial YearRevenueRevenue GrowthNet ProfitProfit Growth
FY 2024-252,198
15.58% Profit
-713
-403.27% Loss
FY 2023-241,902
52.97% Profit
235
143.89% Profit
FY 2022-231,243
33.26% Profit
-536
23.81% Profit

SRPT Similar Stocks

Stock NamePrice
Vertex Pharmaceuticals Inc

V

Vertex Pharmaceuticals Inc

$445.04+0.00%profit
Regeneron Pharmaceuticals Inc

R

Regeneron Pharmaceuticals Inc

$611.48+0.00%profit
argenx SE

A

argenx SE

$898.94+0.00%profit
Alnylam Pharmaceuticals Inc

A

Alnylam Pharmaceuticals Inc

$289.39+0.00%profit
Revolution Medicines Inc

R

Revolution Medicines Inc

$149.23+0.00%profit

US Indices Today

Index NamePrice
View Allarrow

US Top Gainers Today

Stock NamePrice

US Top Losers Today

Stock NamePrice

What's Trending

What's New In The US Market

Invest in US Stocks with Dhan

Start building a global portfolio from just $1.

4.5 ratings

4.0 ratings

Dhan US Stocks App
logo

Join our Community

community logo

Follow us on

twitter
telegram
Linkedin
youtube
instagram
facebook

built with love
for Indians who love to invest & trade

raise

We are part of Raise Financial Services

raise
raise

Explore  |  Sitemap


*All securities mentioned on this website are exemplary and not recommendatory.

*Current prices on the website are delayed by 15 mins, login to check live prices.

We are bullish on India, we are bullish on India's prospects to be one of the largest economies in the world. We believe that the stock market provides a unique opportunity for all of India's traders and investors to participate in the growth story of the country.

Yet, most investing & trading platforms in India have remained more or less the same over the past decade. Times have changed and retail traders and investors have become smarter about managing their trades and money. Modern traders & investors require an online trading platform that helps them keep up with the technological advancements of our time.

That's why we're building Dhan - to help you trade, to help you invest, and to help you participate in India's growth stock via the stock market with awesome features and an incredible experience.

We are doing so by giving you access to not just one but 6 products within the Dhan ecosystem:


This means that with Dhan, you'll be able to start:


Lakhs of users already trust Dhan for their online stock trading and investing needs. Dhan is growing rapidly because of the love we receive from SuperTraders and Long-Term Investors who acknowledge that the platform is innovating for them, building super useful features that help them do everything from investing in stock market to trading F&O like a pro on the Tradingview charts and much more.

While we are growing, we will always remember why we started building in the first place - you. Our user-first approach will always be at the heart of our philosophy. Come join us on this incredible journey!

Try it out, you can close your account at anytime using this link.

©2021-2026 Raise Securities Private Limited (formerly Moneylicious Securities Private Limited). All rights reserved. CIN: U74999MH2012PTC433549 Raise Securities is part of Raise Financial Services and works closely with Raise Partners across services.

SEBI Stock Broker Registration No: INZ000006031 | Depository Participant (CDSL) ID: IN-DP-289-2016 | SEBI Research Analyst Registration No: INH000023357
Exchange Membership No. : NSE: 90133 | BSE: 6593 | MCX: 56320
Registered & Corporate Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai – 400104, Customer Care: 9987761000.

Details of client bank account

For any query / feedback / clarifications, email at help@dhan.co.

In case of grievances for any of the services rendered by Raise Securities Private Limited, please write to grievance@dhan.co (for NSE, BSE and MCX) or grievancedp@dhan.co (for Depository Participant). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms of Use and Privacy Policy. Compliance Officer: Mr. Manish Garg and Mobile: 8655740961 Email: complianceofficer@dhan.co To lodge your complaints using SEBI SCORES, click here.


Disclaimer: All communications with the client via chat, phone, or email are for support purposes only. Any commitments or statements made by the agent (human or virtual) shall not be binding on the company.


DHAN is a brand owned by Raise Securities Private Limited. All DHAN clients are registered under Raise Securities Private Limited. Clients are advised to refer to our company as Raise Securities Private Limited when communicating with regulatory authorities.


Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances. You may refer the website https://scores.sebi.gov.in/ for more information. You may also download the SEBI Scores app to log a complaint Android: https://play.google.com store apps sebiscores iOS: https://apps.apple.com app sebiscores.


Disclaimer: Investment in the securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit


Attention investors:

  1. Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w.e.f September 01, 2020.
  2. Update your e-mail and phone number with your stock broker / depository participant and receive OTP directly from depository on your e-mail and/or mobile number to create pledge.
  3. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: As a policy we do not give stock tips or recommendations and have not authorized anyone to give this on behalf of us. If you know anyone claiming to be a part of Dhan / / Raise or our associate companies or partners and offering such services, please report us on help@dhan.co. Important Information for Investors: To prevent unauthorized transactions in your trading / demat account, do not share your account details, credentials or any personal details with anyone. Keep your mobile number updated with your Stock Broker, Depository Participant and ensure that the same is registered with Stock Exchanges, Depository and KRAs. You will receive alerts and information on your registered mobile number / email for debit and other important transactions in your demat account directly from CDSL / Exchange on the same day. KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Stock Broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach another intermediary. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. This is issued in the interest of investors.


Investors should be cautious on unsolicited emails and SMS advising to buy, sell or hold securities and trade only on the basis of informed decision. Investors are advised to invest after conducting appropriate analysis of respective companies and not to blindly follow unfounded rumours, tips etc. Further, you are also requested to share your knowledge or evidence of systemic wrongdoing, potential frauds or unethical behaviour through the anonymous portal facility provided on BSE & NSE website. Issued in the interest of the investors.


Raise Securities Private Limited also known as Dhan is only an order collection platform that collects orders on behalf of clients and places them on BSE StarMF for execution. Client expressly agrees that Dhan is not liable or responsible and does not represent or warrant any damages regarding non- execution of orders or any incorrect execution of orders with regard to the funds chosen by the client or due to, but not being limited to, any link/system failure, delay in transfer of the funds on account of any unforeseen circumstances/issues in the banking system/payment aggregators or any other problems that may result in a delay in crediting the funds into the BSE Star MF's bank account. Raise Securities Private Limited (Dhan) does not engage in proprietary trading on its own account.


Mutual fund investments are subject to market risks, read all scheme related documents carefully before investing. Dhan is not a distributor or agent of any mutual fund. Mutual Funds are not exchange-traded products. Any related disputes will not have access to the Exchange-investor redressal forum or arbitration mechanism. For other disclaimers please refer https://dhan.co/advertisement-disclaimer/


Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: BSE | NSE | MCX


Kindly, read the Advisory Guidelines of BSE | NSE | MCX for investors as prescribed by the exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client's assets


Important Links: SEBI | BSE | NSE | MCX | CDSL | SCORES | ODR Portal | Investor Charter for Stock Brokers | Investor Charter for DP | Investor Charter for Research Analyst | UCC Advisory | e-Voting for Shareholders | NCL Client Collateral details |
MCXCCL Client Collateral details

Important Information: Terms of Usage | Disclaimers | Privacy Policy | Grievances | Grievances RA | Risk Management Policy | Risk Disclosure | Advertisement Disclaimer | Referral Terms & Conditions | Saarthi 2.0 Mobile App for Investors